by Steven Rudolph | Dec 10, 2018 | News, Uncategorized
The treatment of stroke patients has been characterized by the need for speed. The only medical therapy available, a clot dissolving drug called tPA, was originally available for use only if it could be given less than 3 hours after the start of symptoms. This led to...
by Steven Rudolph | Jun 8, 2017 | News
The window for stroke therapy refers to the time limit after the onset of symptoms when treatment can still be made available. A new study, presented at the European Stroke Organization conference in Prague last month, may extend this window to 24 hours for carefully...
by Steven Rudolph | Mar 13, 2016 | News
The only available drug for the treatment of the most common type of stroke is the clot buster known as tPA. This treatment was first approved by FDA 20 years ago. The cost of tPA jumped by 111% between 2005 and 2014, but reimbursement rose by only 8%, reported Dawn...
by Steven Rudolph | Jan 1, 2015 | News
In 1995 the clot dissolving drug tPA was first demonstrated to be effective in the treatment of the most common type of stroke, those caused by blood clots plugging arteries in the brain. Since that time, no newer therapy has been proven to improve the outcome of...
by Steven Rudolph | Sep 29, 2013 | News
Sleep apnea is a condition which increases the risk of high blood pressure, heart attack, stroke, heart failure, and diabetes and increases the chance of car accidents or other accidents. Sleep apnea is a leading cause of excessive daytime sleepiness. The most common...
